N-ethyl-N-nitrosourea (ENU)-Induced Meningiomatosis and Meningioma in p16INK4a/p19ARF Tumor Suppressor Gene-Deficient Mice

Toxicologic Pathology

Volumn 35, Issue 6, 2007, Pages 838-845

  Morrison, James P ^a   Satoh, Hiroshi ^b   Foley, Julie ^c   Horton, John L ^c   Dunnick, June K ^d   Kissling, Grace E ^e   Malarkey, David E ^c  

^a CHARLES RIVER LABORATORIES   (United States)

^b DAIICHI SANKYO CO   (Japan)

^c Experimental Pathology Laboratories   (United States)

^d Environmental Engineering Program   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Animal model; central nervous system; ethylnitrosourea; meningioma; meningiomatosis; mouse; tumor suppressor gene deficiency

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2D; ETHYLNITROSOUREA; PROTEIN MDM2; PROTEIN P16INK4A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; EMBRYOTOXICITY; FEMALE; GENE DELETION; GENE MUTATION; GENE SILENCING; GESTATION PERIOD; HISTOGENESIS; HISTOPATHOLOGY; MALE; MALIGNANT MENINGIOMA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPINDLE CELL; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

ANIMALIA; MUS;

EID: 35349005698     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230701584130     Document Type: Article

References (26)

1. Avellino AM Hair LS Symmans WF Gold AP Carmel P Powers JM Meningeal meningiomatosis in a child: case report Clin Neuropathol 1994 13 82 7
2. Baia GS Slocum AL Hyer JD Misra A Sehati N Vandenberg SR Feuerstein BG Deen DF McDermott MW Lal A A genetic strategy to overcome the senescence of primary meningioma cell cultures J Neurooncol 2006 78 113 21
3. Bostrom J Meyer-Puttlitz B Wolter M Blaschke B Weber RG Lichter P Ichimura K Collins VP Reifenberger G Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas Am J Pathol 2001 159 661 9
4. Claus EB Bondy ML Schildkraut JM Wiemels JL Wrensch M Black PM Epidemiology of intracranial meningioma Neurosurgery 2005 57 1088 95
5. Kalamarides M Niwa-Kawakita M Leblois H Abramowski V Perricaudet M Janin A Thomas G Gutmann DH Giovannini M Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse Genes Dev 2002 16 1060 5
6. Kamijo T Bodner S van de Kamp E Randle DH Sherr CJ Tumor spectrum in ARF-deficient mice Cancer Res 1999 59 2217 22
7. Kim WY Sharpless NE The regulation of INK4/ARF in cancer and aging Cell 2006 127 265 75
8. Korshunov A Shishkina L Golanov A Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome Int J Cancer 2003 104 728 34
9. Louis DN Scheithauer BW Budka H von Deimling A Kepes JJ Kleihues PC WK Meningiomas World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Nervous System 2000 Lyon IARC Press 176 84
10. Lusis E Gutmann DH Meningioma: an update Curr Opin Neurol 2004 17 687 92
11. Malham GM Thomsen RJ Synek BJ Baguley BC Establishment of primary human meningiomas as subcutaneous xenografts in mice Br J Neurosurg 2001 15 328 34
12. McCutcheon IE Friend KE Gerdes TM Zhang BM Wildrick DM Fuller GN Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth J Neurosurg 2000 92 306 14
13. Perry A Gutmann DH Reifenberger G Molecular pathogenesis of meningiomas J Neurooncol 2004 70 183 202
14. Perry A Scheithauer BW Stafford SL Lohse CM Wollan PC ”Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications Cancer 1999 85 2046 56
15. Perry A Stafford SL Scheithauer BW Suman VJ Lohse CM Meningioma grading: an analysis of histologic parameters Am J Surg Pathol 1997 21 1455 65
16. Rousseau E Ruchoux MM Scaravilli F Chapon F Vinchon M De Smet C Godfraind C Vikkula M CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours Neuropathol Appl Neurobiol 2003 29 574 83
17. Ruas M Peters G The p16INK4a/CDKN2A tumor suppressor and its relatives Biochim Biophys Acta 1998 1378 F115 77
18. Russell DS Rubinstein LJ Tumours of the Meninges and Related Tissues Pathology of Tumours of the Nervous System 1989 Baltimore Williams and Wilkins 512 514
19. Serrano M The INK4a/ARF locus in murine tumorigenesis Carcinogenesis 2000 21 865 9
20. Serrano M Lee H Chin L Cordon-Cardo C Beach D DePinho RA Role of the INK4a locus in tumor suppression and cell mortality Cell 1996 85 27 37
21. Sharpless NE INK4a/ARF: a multifunctional tumor suppressor locus Mutat Res 2005 576 22 38
22. Sharpless NE Bardeesy N Lee KH Carrasco D Castrillon DH Aguirre AJ Wu EA Horner JW DePinho RA Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis Nature 2001 413 86 91
23. Sharpless NE Ramsey MR Balasubramanian P Castrillon DH De-Pinho RA The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis Oncogene 2004 23 379 85
24. Simon M Park TW Koster G Mahlberg R Hackenbroch M Bostrom J Loning T Schramm J Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression J Neurooncol 2001 55 149 58
25. Wakabayashi K Kawasaki K Ono K Nishiyama K Tanaka R Takahashi H Primary leptomeningeal meningiomatosis with widespread whorl formation Brain Tumor Pathol 1997 14 139 43
26. Zook BC Simmens SJ Neurogenic tumors in rats induced by ethylnitrosourea Exp Toxicol Pathol 2005 57 7 14